Gainers
- U.S. Xpress Enterprises, Inc. USX shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.
- Impac Mortgage Holdings, Inc. IMH gained 94.8% to $0.39. Impac Mortgage Holdings recently posted a Q4 adjusted loss of $0.35 per share.
- Cerberus Cyber Sentinel Corporation CISO shares jumped 84.6% to $0.4245. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of $46.5 million.
- Quince Therapeutics, Inc. QNCX gained 74.7% to $1.4708 after Echo Lake Capital offered to acquire the company for $1.60 per share in cash.
- Pear Therapeutics, Inc.. PEAR climbed 39.3% to $0.2919 after dropping 46% on Monday. Pear Therapeutics, last week, said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction.
- First Republic Bank FRC shares climbed 29.7% to $15.80 following reports suggesting JP Morgan CEO Jamie Dimon is leading discussions to come up with a new rescue plan for the bank. Also, Treasury Secretary Yellen said the government is prepared to take more action to aid banks, which could be positively impacting the stock.
- On Holding AG ONON gained 29.1% to $27.85 after the company reported fourth-quarter FY22 sales growth of 91.9% year-on-year to CHF 366.8 million.
- Novo Integrated Sciences, Inc. NVOS jumped 23.7% to $0.1255.
- Torrid Holdings Inc. CURV surged 22.8% to $2.7385.
- EZGO Technologies Ltd. EZGO jumped 22% to $1.23.
- Blue Star Foods Corp. BSFC rose 21.6% to $0.1930.
- So-Young International Inc. SY gained 20.6% to $1.99 following Q4 results.
- ImmunityBio, Inc. IBRX gained 20% to $1.62.
- Novo Integrated Sciences, Inc. NVOS shares rose 19.5% to $0.1213.
- Qualigen Therapeutics, Inc. QLGN jumped 18.3% to $1.16 after the company announced the USPTO granted it patent number 11,560,380 for QN-302, its lead oncology investigational drug candidate.
- Blue Star Foods Corp. BSFC gained 18.3% to $0.1879 after jumping around 22% on Monday.
- CURO Group Holdings Corp. CURO rose 18% to $1.6750.
- Qwest Corp. NT CTBB gained 18% to $12.04.
- Oportun Financial Corporation OPRT shares climbed 17.7% to $3.99.
- Sunlight Financial Holdings Inc. SUNL climbed 16.1% to $0.3525.
- Bird Global, Inc. BRDS gained 13.9% to $0.1257 after declining 8% on Monday. Bird Global recently reported better-than-expected Q4 sales results.
- Select Energy Services, Inc. WTTR jumped 12.5% to $6.30. Select Energy Services announced a $50 million buyback program.
- Canadian Solar Inc. CSIQ surged 12.7% to $40.41 after the company reported better-than-expected Q4 results.
- PacWest Bancorp PACW gained 12.7% to $11.58.
- Puyi Inc. PUYI jumped 11.8% to $7.17. Puyi posted a narrower H1 loss.
- Semantix, Inc. STIX gained 8.3% to $4.2001.
Losers
- Qutoutiao Inc. QTT fell 59.2% to $0.2850 after gaining 3% on Monday.
- Altimmune, Inc. ALT shares dropped 54% to $5.01 after the company announced results from the week 24 interim analysis of pemvidutide MOMENTUM Phase 2 obesity trial and 12-week Phase 1b type 2 diabetes safety trial.
- Check-Cap Ltd. CHEK fell 42.2% to $1.7501. Check-Cap said it 'plans to continue conducting its calibration studies, albeit at a slower pace, to collect additional clinical data and the company is also implementing a cost reduction plan, in order to extend its cash runway.'
- Maxpro Capital Acquisition Corp. JMAC dropped 26% to $9.09.
- First Majestic Silver Corp. AG fell 24.5% to $5.61 after the company temporarily suspended mining activities and reduced its workforce at Jerritt Canyon, which represented 21% of the company's 2022 revenue.
- Jeffs' Brands Ltd JFBR fell 22.6% to $1.03. Jeffs' Brands recently entered into a definitive agreement to acquire the entire share capital of Fort Products Ltd for $1.92 million.
- YS Biopharma Co., Ltd. YS dropped 22% to $10.14.
- SigmaTron International, Inc. SGMA dropped 21.4% to $2.46.
- Allarity Therapeutics, Inc. ALLR shares fell 21.4% to $0.1130. Allarity Therapeutics shares jumped 37% on Monday after the company said it dosed the first patient in its trial studying advanced solid tumors.
- Athenex, Inc. ATNX dropped 19.3% to $1.0168. Ladenburg Thalmann downgraded Athenex from Buy to Neutral.
- Gelesis Holdings, Inc. GLS shares fell 19% to $0.1701 after jumping over 90% on Monday.
- HUB Cyber Security (Israel) Ltd. HUBC dropped 19% to $1.79.
- Bluejay Diagnostics, Inc. BJDX fell 18% to $0.4411. Bluejay Diagnostics posted a FY22 loss of $0.46 per share.
- HUYA Inc. HUYA dropped 16.7% to $3.2650 after the company reported mixed Q4 financial results.
- Connect Biopharma Holdings Limited CNTB fell 15.9% to $1.11 after gaining 20% on Monday. Connect Biopharma announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).
- Citi Trends, Inc. CTRN dropped 14.4% to $19.95 after the company reported Q4 financial results.
- Boxed, Inc. BOXD fell 14.3% to $0.1175 after jumping over 35% on Monday.
- Tencent Music Entertainment Group TME dropped 11.7% to $6.93 after the company reported Q4 financial results.
- Roivant Sciences Ltd. ROIV fell 11% to $7.75.
- Viking Therapeutics, Inc. VKTX declined 9.3% to $10.55.
- GeneDx Holdings Corp. WGS dropped 9.2% to $0.4581.
- Karuna Therapeutics, Inc. KRTX fell 8.5% to $166.76 after the company announced a $400 million offering of common stock.
Now Read This: Wall Street's Most Accurate Analysts Say Hold These 3 Consumer Stocks With Over 5% Dividend Yields
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in